Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
    • Research Interests
    Egfr MutationsNsclcTargeted TherapyBreast CancerEgfr202020102026
    19772025

    Papers共 582 篇Author StatisticsCo-AuthorSimilar Experts

    By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
    时间
    引用量
    主题
    期刊级别
    合作者
    合作机构
    All20252024202320222021202020192018201720162015201420132012201120102009200820072006
    Amivantamab Plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
    The New England journal of medicineno. 6 (2025): 620-621
    Cited1Views12WOSBibtex
    1
    12
    Brief Report: Preventing Infusion-related Reactions with Intravenous Amivantamab: Results from SKIPPirr, a Phase 2 Study
    Alexander I. Spira,Luis Paz-Ares,Ji-Youn Han, Jin-Yuan Shih,Céline Mascaux, Upal Basu Roy,Jon Zugazagoitia,Yu Jung Kim,Chao-Hua Chiu, Sang-We Kim,Ernest Nadal, Ignacio Gil-Bazo, Sean P. Murphy, Bailey G. Anderson, Yichuan Xia, George Wang, Joshua M. Bauml, Marc Chioda, Jairo Simoes, Parthiv J. Mahadevia
    Journal of Thoracic Oncology (2025)
    Cited0Views3WOSBibtex
    0
    3
    2 Oral: Preliminary Results from SEACRAFT-1: an Open-Label Study of Naporafenib with Trametinib in Patients with Locally Advanced Unresectable or Metastatic Solid Tumor Malignancies with RAS Q61X Mutations
    E. Fontana,A.I. Spira, M. McKean, J. Lee, N. Chau, E. Winquist, I. Kim, S.H. Hong,B.A. Van Tine, A. Fawole, R. Shoemaker, Y. Cui, R. Sutton, J.M. Antal, S.R. Morris, D.S. Hong
    European Journal of Cancer (2024): 114531
    Cited0Views1Bibtex
    0
    1
    Preventing Infusion-Related Reactions with Intravenous Amivantamab: Primary Results from SKIPPirr, a Phase 2 Study
    G. Lopes,A. I. Spira, J. -Y. Han,J. -Y. Shih, C. Mascaux, U. Basu Roy,J. Zugazagoitia, Y. J. Kim,C. -H. Chiu, S. -W. Kim, E. Nadal,I. Gil-Bazo, S. Murphy,P. Mahadevia, B. G. Anderson, K. Xia, G. Wang,J. M. Bauml,M. Chioda, J. Simoes, L. Paz-Ares
    JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S104-S105
    Cited0Views0Bibtex
    0
    0
    Load More
    Author Statistics
    00.20.40.60.81#Papers#CitationH-IndexG-IndexSociabilityDiversityActivity

    #Papers: 582

    #Citation: 19078

    H-Index: 50

    G-Index: 134

    Sociability: 8

    Diversity: 2

    Activity: 557

    Loading...
    • 合作者
    • 学生
    • 导师
    Melissa L. Johnson合作论文数
    Sarah Cannon Research Institute;TriStar Centennial Medical Center42
    Erika Hamilton合作论文数
    40
    Enriqueta Felip合作论文数
    Lung Cancer Unit, Oncology Department, Vall d’Hebron University Hospital35
    Cho, Byoung Chul合作论文数
    Severance Biomedical Science Institute;Yuhan-Yonsei Lung Cancer Clinical and Translational Medicine Center;Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine;Lung Cancer Center, Yonsei Cancer Center, Yonsei University College of Medicine35
    Shirish M. Gadgeel合作论文数
    Division of Hematology & Oncology, Department of Internal Medicine, Henry Ford Cancer Institute33
    Pasi A. Jänne合作论文数
    Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Harvard Medical School, Harvard University;Division of Medical Sciences, Harvard Medical School, Harvard University;Dana-Farber Cancer Institute30
    James Chih-Hsin Yang (楊志新)合作论文数
    Graduate Institute of Oncology, College of Medicine, National Taiwan University;Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University;National Taiwan University Cancer Center28
    Stephen Liu合作论文数
    Georgetown Lombardi Comprehensive Cancer Center, Georgetown University28
    Rachel Sanborn合作论文数
    Earle A. Chiles Research Institute, Providence Cancer Institute28
    Sai-Hong Ignatius Ou合作论文数
    Division of Hematology/Oncology, School of Medicine, University of California Irvine27
    Joshua Michael Bauml合作论文数
    The Janssen Pharmaceutical Companies of Johnson & Johnson26
    Rebecca Heist合作论文数
    Massachusetts General Hospital, Harvard Medical School;Cancer Center, Mass General Research Institute26
    ANTHONY W. TOLCHER合作论文数
    Medical Oncology, Texas Oncology-San Antonio Babcock Next Oncology25
    John Powderly合作论文数
    Carolina BioOncology Institute;BioCytics Human Applications Lab;Duke University Medical Center24
    Funda Meric-Bernstam合作论文数
    Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center23
    D. Ross Camidge合作论文数
    Division of Medical Oncology, School of Medicine, University of Colorado22
    Hirva Mamdani合作论文数
    Department of Oncology,Karmanos Cancer Institute,Detroit22
    Robert M. Jotte合作论文数
    21
    Hossein Borghaei合作论文数
    Department of Hematology, Fox Chase Cancer Center;Department of Oncology, Fox Chase Cancer Center21
    Minal Barve合作论文数
    20
    Joshua K. Sabari合作论文数
    Dept Pathol, NYU Langone Hlth20
    Misako Nagasaka合作论文数
    20
    David R. Spigel合作论文数
    Sarah Cannon Cancer Institute;TriStar Centennial Medical Center;SCRI Oncology Partners;HCA Centennial Medical Center20
    Jonathan Goldman合作论文数
    Department of Medicine, University of California Los Angeles20
    Helena A. Yu合作论文数
    Weill Cornell Medical College;Memorial Sloan Kettering Cancer Center19
    Edward B. Garon合作论文数
    Jonsson Comprehensive Cancer Center, UCLA Health;UCLA Medical Center, Santa Monica;David Geffen School of Medicine, University of California Los Angeles19
    Kim Edward S合作论文数
    19
    Aaron Lisberg合作论文数
    17
    Socinski Mark A合作论文数
    17
    Toshio Shimizu合作论文数
    17
    Ji-Youn Han合作论文数
    Center for Lung Cancer, National Cancer Center Hospital;Division of Precision medicine, National Cancer Center17
    Nashat Y. Gabrail合作论文数
    17
    Antoinette J. Wozniak合作论文数
    Department of Oncology, Hillman Cancer Center, University of Pittsburgh17
    Greenberg Jonathan合作论文数
    16
    Nicolas Girard合作论文数
    15
    VanderWalde Ari合作论文数
    Global Development-Oncology, Amgen Inc15
    Manish R Sharma合作论文数
    Departments of Medicine and Health Studies, University of Chicago15
    Kobayashi Fumiaki合作论文数
    15
    Gregory J. Riely合作论文数
    Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College15
    Jorge Nieva合作论文数
    Molecular and Experimental Medicine, The Scripps Research Institute15
    David S Hong合作论文数
    Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center15
    Lyudmila Bazhenova合作论文数
    Vc-health Sciences-schools, University of California San Diego14
    Shivaani Kummar合作论文数
    Division of Hematology/Medical Oncology, School of Medicine, Oregon Health & Science University14
    James Christensen合作论文数
    Mirati Therapeutics, Inc.14
    Richard C. Chao合作论文数
    14
    Fadi Braiteh合作论文数
    13
    Meredith McKean合作论文数
    13
    Yui Kawasaki合作论文数
    13
    David Sommerhalder合作论文数
    13
    No result temporarily, you can search similar Scholar with the same research interest
    Data Disclaimer
    The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn